Mark Corrigan - 16 Aug 2021 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
Director
Signature
/s/ Mark Corrigan
Issuer symbol
WVE
Transactions as of
16 Aug 2021
Net transactions value
$0
Form type
4
Filing time
18 Aug 2021, 18:09:43 UTC
Previous filing
30 Jul 2021
Next filing
04 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction WVE Share Option (right to buy) Award $0 +21,000 $0.000000 21,000 16 Aug 2021 Ordinary Shares 21,000 $5.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person was granted this option pursuant to the Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2022 annual general meeting or August 16, 2022.